World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking National Ranking Publications Citations
Chemistry 57 10914 616 195 20694

Daniel F. Veber publications per year

The chart shows the history of publications by Daniel F. Veber between 1960 and 2015, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Daniel F. Veber published across 56 years, from 1960 to 2015, averaging 4.5 papers a year. Output peaked at 16 publications in 1999. 6 of the 253 publications appeared in the last two years.

No. of publications
5 10 15
Bar chart. Horizontal axis: year, 1960 to 2015. Vertical axis: number of publications, 0 to 16. Peak 16 publications in 1999. 1960: 1 publication 1961: 0 publications 1962: 1 publication 1963: 1 publication 1964: 0 publications 1965: 0 publications 1966: 1 publication 1967: 2 publications 1968: 3 publications 1969: 5 publications 1970: 1 publication 1971: 4 publications 1972: 2 publications 1973: 1 publication 1974: 0 publications 1975: 0 publications 1976: 1 publication 1977: 2 publications 1978: 4 publications 1979: 6 publications 1980: 4 publications 1981: 4 publications 1982: 2 publications 1983: 2 publications 1984: 5 publications 1985: 5 publications 1986: 8 publications 1987: 12 publications 1988: 3 publications 1989: 2 publications 1990: 8 publications 1991: 3 publications 1992: 4 publications 1993: 9 publications 1994: 4 publications 1995: 10 publications 1996: 5 publications 1997: 11 publications 1998: 8 publications 1999: 16 publications 2000: 8 publications 2001: 10 publications 2002: 11 publications 2003: 8 publications 2004: 11 publications 2005: 3 publications 2006: 5 publications 2007: 5 publications 2008: 5 publications 2009: 8 publications 2010: 4 publications 2011: 4 publications 2012: 2 publications 2013: 3 publications 2014: 4 publications 2015: 2 publications
1960 2015

253 publications in total across all disciplines

View publications per year as a table
Daniel F. Veber: publications per year, 1960 to 2015
Year Publications
1960 1
1961 0
1962 1
1963 1
1964 0
1965 0
1966 1
1967 2
1968 3
1969 5
1970 1
1971 4
1972 2
1973 1
1974 0
1975 0
1976 1
1977 2
1978 4
1979 6
1980 4
1981 4
1982 2
1983 2
1984 5
1985 5
1986 8
1987 12
1988 3
1989 2
1990 8
1991 3
1992 4
1993 9
1994 4
1995 10
1996 5
1997 11
1998 8
1999 16
2000 8
2001 10
2002 11
2003 8
2004 11
2005 3
2006 5
2007 5
2008 5
2009 8
2010 4
2011 4
2012 2
2013 3
2014 4
2015 2
Total 253
Download as CSV

Daniel F. Veber publication distribution in Chemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Chemistry in 2026. The highlighted bar marks where Daniel F. Veber sits on this spectrum.

No. of scientists
250 500 750 1,000 1,250
Bar chart with 63 bars. Horizontal axis: publications, 61–80 to 1,295+. Vertical axis: number of scientists, 0 to 1,350. Most scientists, 1,350, have 161–180 publications. The last bar groups every scientist with 1,295 publications or more. The highlighted bar, 181–200 publications, is where this scientist sits. 61–80 publications: 66 scientists 81–100 publications: 302 scientists 101–120 publications: 623 scientists 121–140 publications: 918 scientists 141–160 publications: 1,218 scientists 161–180 publications: 1,350 scientists 181–200 publications: 1,344 scientists 201–220 publications: 1,281 scientists 221–240 publications: 1,216 scientists 241–260 publications: 1,100 scientists 261–280 publications: 979 scientists 281–300 publications: 939 scientists 301–320 publications: 764 scientists 321–340 publications: 643 scientists 341–360 publications: 628 scientists 361–380 publications: 522 scientists 381–400 publications: 459 scientists 401–420 publications: 397 scientists 421–440 publications: 327 scientists 441–460 publications: 270 scientists 461–480 publications: 265 scientists 481–500 publications: 252 scientists 501–520 publications: 201 scientists 521–540 publications: 185 scientists 541–560 publications: 148 scientists 561–580 publications: 148 scientists 581–600 publications: 132 scientists 601–620 publications: 114 scientists 621–640 publications: 104 scientists 641–660 publications: 91 scientists 661–680 publications: 92 scientists 681–700 publications: 73 scientists 701–720 publications: 57 scientists 721–740 publications: 54 scientists 741–760 publications: 67 scientists 761–780 publications: 45 scientists 781–800 publications: 46 scientists 801–820 publications: 39 scientists 821–840 publications: 32 scientists 841–860 publications: 36 scientists 861–880 publications: 29 scientists 881–900 publications: 26 scientists 901–920 publications: 24 scientists 921–940 publications: 14 scientists 941–960 publications: 23 scientists 961–980 publications: 28 scientists 981–1,000 publications: 15 scientists 1,001–1,020 publications: 29 scientists 1,021–1,040 publications: 12 scientists 1,041–1,060 publications: 19 scientists 1,061–1,080 publications: 12 scientists 1,081–1,100 publications: 6 scientists 1,101–1,120 publications: 8 scientists 1,121–1,140 publications: 12 scientists 1,141–1,160 publications: 5 scientists 1,161–1,180 publications: 6 scientists 1,181–1,200 publications: 14 scientists 1,201–1,220 publications: 7 scientists 1,221–1,240 publications: 2 scientists 1,241–1,260 publications: 6 scientists 1,261–1,280 publications: 4 scientists 1,281–1,294 publications: 6 scientists 1,295+ publications: 100 scientists
61–80 publications 1,295+

This scientist: 195 publications — 31st percentile

31% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,295 publications or more.

View publications distribution as a table
Number of Chemistry scientists by publication count, Research.com 2026 ranking edition. Based on 17,934 ranked scientists.
Publications Scientists This scientist
61–80 66
81–100 302
101–120 623
121–140 918
141–160 1,218
161–180 1,350
181–200 1,344 195
201–220 1,281
221–240 1,216
241–260 1,100
261–280 979
281–300 939
301–320 764
321–340 643
341–360 628
361–380 522
381–400 459
401–420 397
421–440 327
441–460 270
461–480 265
481–500 252
501–520 201
521–540 185
541–560 148
561–580 148
581–600 132
601–620 114
621–640 104
641–660 91
661–680 92
681–700 73
701–720 57
721–740 54
741–760 67
761–780 45
781–800 46
801–820 39
821–840 32
841–860 36
861–880 29
881–900 26
901–920 24
921–940 14
941–960 23
961–980 28
981–1,000 15
1,001–1,020 29
1,021–1,040 12
1,041–1,060 19
1,061–1,080 12
1,081–1,100 6
1,101–1,120 8
1,121–1,140 12
1,141–1,160 5
1,161–1,180 6
1,181–1,200 14
1,201–1,220 7
1,221–1,240 2
1,241–1,260 6
1,261–1,280 4
1,281–1,294 6
1,295+ 100
Download as CSV

Daniel F. Veber D-index placement in Chemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Chemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Daniel F. Veber sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 61 bars. Horizontal axis: D-Index, 40–41 to 159+. Vertical axis: number of scientists, 0 to 1,051. Most scientists, 1,051, have 56–57 D-Index. The last bar groups every scientist with 159 D-Index or more. The highlighted bar, 56–57 D-Index, is where this scientist sits. 40–41 D-Index: 289 scientists 42–43 D-Index: 612 scientists 44–45 D-Index: 808 scientists 46–47 D-Index: 776 scientists 48–49 D-Index: 835 scientists 50–51 D-Index: 861 scientists 52–53 D-Index: 872 scientists 54–55 D-Index: 933 scientists 56–57 D-Index: 1,051 scientists 58–59 D-Index: 930 scientists 60–61 D-Index: 882 scientists 62–63 D-Index: 834 scientists 64–65 D-Index: 731 scientists 66–67 D-Index: 775 scientists 68–69 D-Index: 683 scientists 70–71 D-Index: 646 scientists 72–73 D-Index: 561 scientists 74–75 D-Index: 501 scientists 76–77 D-Index: 437 scientists 78–79 D-Index: 388 scientists 80–81 D-Index: 354 scientists 82–83 D-Index: 292 scientists 84–85 D-Index: 275 scientists 86–87 D-Index: 254 scientists 88–89 D-Index: 235 scientists 90–91 D-Index: 185 scientists 92–93 D-Index: 192 scientists 94–95 D-Index: 155 scientists 96–97 D-Index: 163 scientists 98–99 D-Index: 125 scientists 100–101 D-Index: 105 scientists 102–103 D-Index: 105 scientists 104–105 D-Index: 112 scientists 106–107 D-Index: 88 scientists 108–109 D-Index: 68 scientists 110–111 D-Index: 69 scientists 112–113 D-Index: 65 scientists 114–115 D-Index: 79 scientists 116–117 D-Index: 61 scientists 118–119 D-Index: 44 scientists 120–121 D-Index: 37 scientists 122–123 D-Index: 40 scientists 124–125 D-Index: 33 scientists 126–127 D-Index: 26 scientists 128–129 D-Index: 34 scientists 130–131 D-Index: 35 scientists 132–133 D-Index: 25 scientists 134–135 D-Index: 27 scientists 136–137 D-Index: 17 scientists 138–139 D-Index: 16 scientists 140–141 D-Index: 20 scientists 142–143 D-Index: 20 scientists 144–145 D-Index: 15 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 9 scientists 150–151 D-Index: 16 scientists 152–153 D-Index: 11 scientists 154–155 D-Index: 9 scientists 156–157 D-Index: 3 scientists 158 D-Index: 3 scientists 159+ D-Index: 98 scientists
40–41 D-Index 159+

This scientist: 57 D-Index — 39th percentile

39% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 159 D-Index or more.

View D-Index distribution as a table
Number of Chemistry scientists by D-index, Research.com 2026 ranking edition. Based on 17,934 ranked scientists.
D-Index Scientists This scientist
40–41 289
42–43 612
44–45 808
46–47 776
48–49 835
50–51 861
52–53 872
54–55 933
56–57 1,051 57
58–59 930
60–61 882
62–63 834
64–65 731
66–67 775
68–69 683
70–71 646
72–73 561
74–75 501
76–77 437
78–79 388
80–81 354
82–83 292
84–85 275
86–87 254
88–89 235
90–91 185
92–93 192
94–95 155
96–97 163
98–99 125
100–101 105
102–103 105
104–105 112
106–107 88
108–109 68
110–111 69
112–113 65
114–115 79
116–117 61
118–119 44
120–121 37
122–123 40
124–125 33
126–127 26
128–129 34
130–131 35
132–133 25
134–135 27
136–137 17
138–139 16
140–141 20
142–143 20
144–145 15
146–147 9
148–149 9
150–151 16
152–153 11
154–155 9
156–157 3
158 3
159+ 98
Download as CSV

Overview

Daniel F. Veber is affiliated with GlaxoSmithKline in the United Kingdom. Their professional involvement is primarily situated within the pharmaceutical industry, focusing on areas relevant to GlaxoSmithKline's research and development efforts.

There are no documented recent papers, frequent co-authors, or specific publication venues linked to Daniel F. Veber. Similarly, information about book publications, main fields of study, subfields of study, or main topics of research work is not available.

This profile is based on the accessible data regarding professional affiliation, without additional bibliometric or thematic details on scientific contributions or collaborative networks.

Best Publications

  • Molecular properties that influence the oral bioavailability of drug candidates.

    Daniel F. Veber;Stephen R. Johnson;Hung-Yuan Cheng;Brian R. Smith

  • A potent cyclic hexapeptide analogue of somatostatin

    Veber Df;Freidlinger Rm;Perlow Ds;Paleveda Wj

  • Benzodiazepine gastrin and brain cholecystokinin receptor ligands; L-365,260

    Mark G. Bock;Robert M. DiPardo;Ben E. Evans;Kenneth E. Rittle

  • Design of potent, orally effective, nonpeptidal antagonists of the peptide hormone cholecystokinin

    Ben E. Evans;Mark G. Bock;Kenneth E. Rittle;Robert M. Dipardo

  • Compounds and methods

    Joseph P. Marino;Scott K. Thompson;Daniel Frank Veber

  • Acetamidomethyl. A Novel Thiol Protecting Group for Cysteine

    Daniel Veber;John Milkowski;Sandor Varga;Robert Denkewalter

  • Protected lactam-bridged dipeptides for use as conformational constraints in peptides

    Roger M. Freidinger;Debra Schwenk Perlow;Daniel F. Veber

  • Peptide Aldehyde Inhibitors of Cathepsin K Inhibit Bone Resorption Both In Vitro and In Vivo

    Bartholomew J. Votta;Mark A. Levy;Alison Badger;Jeremy Bradbeer

  • Bioactive conformation of luteinizing hormone-releasing hormone: evidence from a conformationally constrained analog.

    Unknown

  • Novel renin inhibitors containing the amino acid statine

    Joshua Boger;Nancy S. Lohr;Edgar H. Ulm;Martin Poe

  • 4-Aryl-1,2,3-triazole: a novel template for a reversible methionine aminopeptidase 2 inhibitor, optimized to inhibit angiogenesis in vivo.

    Lara S. Kallander;Qing Lu;Wenfang Chen;Thaddeus Tomaszek

  • Conformationally restricted bicyclic analogs of somatostatin.

    Daniel F. Veber;Frederick W. Holly;William J. Paleveda;Ruth F. Nutt

  • Highly active cyclic and bicyclic somatostatin analogues of reduced ring size

    Unknown

  • A stereocontrolled synthesis of hydroxyethylene dipeptide isosteres using novel, chiral aminoalkyl epoxides and .gamma.-(aminoalkyl)-.gamma.-lactones

    Ben E. Evans;Kenneth E. Rittle;Carl F. Homnick;James P. Springer

  • Design of potent and selective human cathepsin K inhibitors that span the active site

    S K Thompson;S M Halbert;M J Bossard;T A Tomaszek

  • Potent and selective inhibition of human cathepsin K leads to inhibition of bone resorption in vivo in a nonhuman primate.

    George B. Stroup;Michael W. Lark;Daniel F. Veber;Amit Bhattacharyya

  • Studies on the total synthesis of an enzyme. V. The preparation of enzymatically active material.

    Ralph Hirschmann;Ruth F. Nutt;Daniel F. Veber;Ronald A. Vitali

  • Protodetachable Arylsilane Polymer Linkages for Use in Solid Phase Organic Synthesis

    Joseph A. Finkelstein;Balan Chenera;Daniel F. Veber

  • Practical synthesis of cyclic peptides, with an example of dependence of cyclization yield upon linear sequence

    Stephen F. Brady;Sandor L. Varga;Roger M. Freidinger;Debra A. Schwenk

  • A highly potent inhibitor of cathepsin K (relacatib) reduces biomarkers of bone resorption both in vitro and in an acute model of elevated bone turnover in vivo in monkeys

    S. Kumar;L. Dare;J.A. Vasko-Moser;I.E. James

  • Chemical synthesis of echistatin, a potent inhibitor of platelet aggregation from Echis carinatus: synthesis and biological activity of selected analogs.

    Victor M. Garsky;Patricia K. Lumma;Roger M. Freidinger;Steven M. Pitzenberger

  • The Controlled Synthesis of Peptides in Aqueous Medium. I. The Use of α-Amino Acid N-Carboxyanhydrides

    Robert G. Denkewalter;H. Schwam;R. G. Strachan;Thomas E. Beesley

Frequent Co-Authors

Ralph Hirschmann
Ralph Hirschmann University of Pennsylvania
Cheryl A. Janson
Cheryl A. Janson Roche (Switzerland)
Byron H. Arison
Byron H. Arison MSD (United States)
Steven A. Carr
Steven A. Carr Broad Institute
George P. Vlasuk
George P. Vlasuk Navitor Pharmaceuticals
Amy A. Sarjeant
Amy A. Sarjeant Bristol Myers Squibb
Raymond Baker
Raymond Baker MSD (United States)

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Chemistry in the USA opens doors to various exciting career paths, many of which can be pursued through specialized online degrees. For those interested in the pharmaceutical industry, understanding the pharmaceutical sales rep salary and career prospects is crucial. This role combines scientific knowledge with strong communication skills to promote medical products effectively.

Becoming a healthcare professional, such as a pharmacist, requires even more dedication. The path involves extensive education, and knowing how much schooling to be a pharmacist can help students plan their academic journey accordingly.

For those intrigued by forensic science, a career as a forensic autopsy technician can be both impactful and rewarding. Learning about the role's responsibilities and salary expectations will aid in making informed decisions. Explore the details on being a forensic autopsy technician.

Additionally, students seeking affordable education options should consider the cheapest online forensic science degree programs. These programs provide a cost-effective way to enter the rapidly growing field of forensic science with flexibility.

Best Scientists Citing Daniel F. Veber

Recently Published Articles